News Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1/2 Study of DSP-5336 Apr 08, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News RS Oncology, LLC Announces Initiation of Patient Dosing in Phase 1/2 MITOPE Clinical Trial of RSO-21 for the Treatment of Patients with Solid Tumors Apr 05, 2022 Posted by RS Oncology LLC
News SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory (Devens, MA) Mar 31, 2022 Posted by SEQENS CDMO NA
News Buy (More) American: Final Rule Falls Short of Previewed Changes But Still Has Major Implications for Life Sciences and Other Companies Mar 29, 2022 Posted by Sidley Austin
News Clinical Trial Enrollment: OIG Approves Another Patient Cost-Sharing Proposal Designed to Increase Socioeconomic Diversity Mar 29, 2022 Posted by Sidley Austin